Total Payments
$4,891
2024 Payments
$812.93
Companies
31
Transactions
297
Medicare Patients
2,859
Medicare Billing
$238,371
Payment Breakdown by Category
Food & Beverage$4,878 (99.7%)
Education$13.60 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,878 | 296 | 99.7% |
| Education | $13.60 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $751.58 | 47 | $0 (2024) |
| ABBVIE INC. | $669.16 | 46 | $0 (2024) |
| Lilly USA, LLC | $603.11 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $441.15 | 32 | $0 (2024) |
| Amarin Pharma Inc. | $320.02 | 16 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $245.51 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $240.31 | 14 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $226.99 | 13 | $0 (2024) |
| PFIZER INC. | $202.31 | 12 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $139.66 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $812.93 | 41 | ABBVIE INC. ($156.36) |
| 2023 | $784.94 | 43 | AbbVie Inc. ($180.02) |
| 2022 | $629.27 | 38 | ABBVIE INC. ($127.15) |
| 2021 | $768.31 | 52 | AbbVie Inc. ($205.63) |
| 2020 | $611.26 | 41 | AstraZeneca Pharmaceuticals LP ($122.21) |
| 2019 | $563.14 | 33 | Amarin Pharma Inc. ($200.66) |
| 2018 | $372.64 | 25 | Novo Nordisk Inc ($135.28) |
| 2017 | $348.86 | 24 | Lilly USA, LLC ($124.80) |
All Payment Transactions
297 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Obesity | ||||||
| 11/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Endocrinology | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.90 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Gastroenterology | ||||||
| 10/07/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $30.50 | General |
| Category: Endocrinology | ||||||
| 10/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Gastroenterology | ||||||
| 09/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Obesity | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: SCHIZOPHRENIA | ||||||
| 07/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Oncology | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Cardio-renal | ||||||
| 06/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 431 | 893 | $115,910 | $51,669 |
| 2022 | 14 | 554 | 1,263 | $150,155 | $63,184 |
| 2021 | 18 | 1,223 | 1,906 | $187,400 | $76,588 |
| 2020 | 13 | 651 | 1,239 | $141,035 | $46,930 |
Total Patients
2,859
Total Services
5,301
Medicare Billing
$238,371
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 415 | $68,475 | $31,397 | 45.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 24 | 178 | $17,800 | $7,293 | 41.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 15 | $4,500 | $2,939 | 65.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $4,250 | $2,127 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 37 | $4,625 | $2,105 | 45.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 51 | $4,335 | $1,908 | 44.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 33 | $990.00 | $970.20 | 98.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 27 | $2,700 | $910.55 | 33.7% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 22 | 23 | $1,150 | $470.58 | 40.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 26 | 26 | $2,210 | $463.32 | 21.0% |
| Q3014 | Telehealth originating site facility fee | Office | 2023 | 14 | 23 | $1,495 | $449.00 | 30.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 11 | $2,035 | $443.52 | 21.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $1,105 | $111.60 | 10.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 24 | $240.00 | $81.84 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 470 | $77,550 | $35,554 | 45.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 37 | 262 | $26,200 | $12,444 | 47.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 115 | $14,375 | $6,060 | 42.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 26 | 83 | $8,300 | $2,736 | 33.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 49 | $4,165 | $2,035 | 48.9% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 35 | 60 | $3,900 | $1,023 | 26.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 29 | $870.00 | $841.01 | 96.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 40 | 40 | $3,400 | $741.71 | 21.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 12 | $2,220 | $508.47 | 22.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 35 | 61 | $5,185 | $486.39 | 9.4% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 23 | 23 | $1,150 | $461.61 | 40.1% |
About Dr. Bruce Berwald, MD
Dr. Bruce Berwald, MD is a Internal Medicine healthcare provider based in Bridgeton, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376647644.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Berwald, MD has received a total of $4,891 in payments from pharmaceutical and medical device companies, with $812.93 received in 2024. These payments were reported across 297 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,878).
As a Medicare-enrolled provider, Berwald has provided services to 2,859 Medicare beneficiaries, totaling 5,301 services with total Medicare billing of $238,371. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bridgeton, MO
- Active Since 09/08/2006
- Last Updated 01/15/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1376647644
Products in Payments
- Ozempic (Drug) $427.23
- VRAYLAR (Drug) $369.13
- FARXIGA (Drug) $334.86
- Vascepa (Drug) $320.02
- UBRELVY (Drug) $237.85
- REXULTI (Drug) $226.99
- XARELTO (Drug) $223.88
- TRULICITY (Drug) $218.23
- LEQVIO (Drug) $176.13
- JARDIANCE (Drug) $172.57
- QULIPTA (Drug) $133.62
- MOUNJARO (Drug) $119.06
- Kerendia (Drug) $118.86
- Rybelsus (Drug) $102.93
- ELIQUIS (Drug) $76.18
- ENTRESTO (Drug) $69.38
- Tresiba (Drug) $69.26
- TRADJENTA (Drug) $64.19
- XIFAXAN (Drug) $62.73
- JANUVIA (Drug) $59.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bridgeton
Ekram Hanna, Md, MD
Internal Medicine — Payments: $43,235
Internal Medicine $43,235
Mr. Fiore Copare, M.d, M.D
Internal Medicine — Payments: $6,700
Internal Medicine $6,700
Dr. John Hatzantonis, Md, MD
Internal Medicine — Payments: $3,990
Internal Medicine $3,990
Dr. Chotchai Boonkham, M.d, M.D
Internal Medicine — Payments: $3,785
Internal Medicine $3,785
Jack Shields, M.d, M.D
Internal Medicine — Payments: $3,699
Internal Medicine $3,699
Randa Sawaf-Hajji, Md, MD
Internal Medicine — Payments: $3,102
Internal Medicine $3,102